"10.1371_journal.pone.0039513","none","2012-09-26T00:00:00Z","Wenying Yang; Wenhui Zhao; Jianzhong Xiao; Rui Li; Ping Zhang; Katarzyna Kissimova-Skarbek; Erin Schneider; Weiping Jia; Linong Ji; Xiaohui Guo; Zhongyan Shan; Jie Liu; Haoming Tian; Li Chen; Zhiguang Zhou; Qiuhe Ji; Jiapu Ge; Gang Chen; Jonathan Brown","Chinese-Japanese Friendship Hospital, Beijing, People's Republic of China; Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland; International Diabetes Federation, Brussels, Belgium; National Bureau of Asian Research, Seattle, Washington, United States of America; Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China; Peking University People's Hospital, Beijing, People's Republic of China; Peking University First Hospital, Beijing, People's Republic of China; First Affiliated Hospital, Chinese Medical University, Shenyang, Liaoling, People's Republic of China; Shanxi Province People's Hospital, Taiyuan, Shaanxi, People's Republic of China; West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China; Xiangya Second Hospital, Changsha, Hunan, People's Republic of China; Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China; Xinjiang Uygur Autonomous Region's Hospital, Urmqi, Xinjiang, People's Republic of China; Fujian Provincial Hospital, Fuzhou, Fujiang, People's Republic of China","Conceived and designed the experiments: JBB RL PZ KS WY JX WZ. Performed the experiments: WZ WJ LJ XG ZS JL HT LC ZZ QJ JG GC. Analyzed the data: JB ES RL PZ. Wrote the paper: JB ES RL PZ KS WY.","Before retirement in 11/09 J. Brown led or could have led studies funded by research contracts with Novo Nordisk, GSK, Takeda Pharmaceuticals North America, Eli Lilly, and Merck. J. Brown had no consulting or other paid or unpaid arrangements with these or other actual or potential commercial funders. Starting in 2002 J. Brown led the creation of the IDF Economic Studies Fund with funds from Novo Nordisk, GSK, Takeda, Eli Lilly, and Merck. As per the rules of the Fund established before solicitation, the funders did not participate in decisions regarding countries to be studied or in doing, analyzing or writing up any study. Since election in Oct 2009 as unpaid IDF VP, J. Brown has accepted no grants or contracts or gifts or employment from any drug or device firms and has not accepted any positions on their editorial or advisory groups. In 2010, J. Brown accepted travel reimbursement from Novo Nordisk to speak at the 6th International Symposium on Diabetes and Pregnancy. In 2009, at the request of IDF, J. Brown accepted reimbursement from IDF to speak at a satellite meeting of ADA sponsored by Roche and Co. Drs. Ping Zhang and Rui Li worked on this project on their own time while in the employ of the United States Center for Disease Control. Drs. Zhang and Li declare that no potential competing interests exist. During most of this study Dr. Skarbek was an employee of the IDF. IDF is supported financially by many commercial entities. She declares that no competing interests exist. All other authors have no potentially competing interests. The authors declare that none of the competing interests described above will alter the authors' adherence to all the PLOS One policies on sharing data and materials.","2012","09","Wenying Yang","WY",19,FALSE,7,12,4,6,TRUE,FALSE,FALSE,0,NA,FALSE
